Effective humoral and cellular immunoprotective responses in Li ESAp-MDP vaccinated protected dogs

Veterinary Immunology and Immunopathology

Volumn 128, Issue 1-3, 2009, Pages 71-78

  Bourdoiseau, G ^a   Hugnet, C ^b   Gonçalves, R Bras ^c   Vezilier F ^c   Petit Didier, E ^c   Papierok, G ^d   Lemesre, J L ^c  

^a UNIVERSITÉ DE LYON   (France)

^b CLINIQUE VÉTÉRINAIRE   (France)

^c INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^d Bio Véto Test ^*  (France)

Author keywords

Antibodies; Cell mediated immunity; Humoral immunity; Leishmania; Vaccinated and placebo dogs

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2; LEISHMANIA VACCINE; MURAMYL DIPEPTIDE; PROTOZOON ANTIBODY;

ACTIVE IMMUNIZATION; AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DOG; DOG DISEASE; FEMALE; HUMORAL IMMUNITY; INOCULATION; LEISHMANIA INFANTUM; LEISHMANIN SKIN TEST; MACROPHAGE FUNCTION; MALE; MONOCYTE; NONHUMAN; PARASITE DEVELOPMENT; PARASITE SURVIVAL; PARASITE VIRULENCE; PROMASTIGOTE; VACCINATION; VISCERAL LEISHMANIASIS;

ANIMALS; ANTIBODIES, PROTOZOAN; CELL PROLIFERATION; DOG DISEASES; DOGS; FEMALE; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNOGLOBULIN G; LEISHMANIA INFANTUM; LEISHMANIASIS, VISCERAL; MACROPHAGES; MALE; MONOCYTES; PROTOZOAN VACCINES;

CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 60849127865     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.10.309     Document Type: Article

References (32)

1. Adler S. Leishmania. Adv. Parasitol. 15 (1964) 35-96
2. Alexander J., and Phillips R.S. Leishmania mexicana and Leishmania tropica major: adoptive transfer of immunity in mice. Exp. Parasitol. 49 (1980) 34-40
3. Anderson S., David J.R., and McMahon-Pratt D. In vivo protection against Leishmania mexicana mediated by monoclonal antibodies. J. Immunol. 131 (1983) 1616-1618
4. Bogdan C., and Rollinghoff M. The immune response to Leishmania: mechanisms of parasite control and evasion. Int. J. Parasitol. 28 (1998) 121-134
5. Bourdoiseau G., Bonnefont C., Hoareau E., Boehringer C., Stolle T., and Chabanne L. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs. Vet. Immunol. Immunopathol. 59 (1997) 21-30
6. Bourdoiseau G., Bonnefont C., Magnol J.P., Siant-André I., and Chabanne L. Lymphocyte subset abnormalities in canine leishmaniasis. Vet. Immunol. Immuopathol. 56 (1997) 345-351
7. Bourdoiseau G., Hugnet C., Papierok G.M., and Lemesre J.-L. La leishmaniose canine à Leishmania infantum: essais d'immunothérapie. Bull. Acad. Vét. France 157 (2004) 63-67
8. Cabral M., O'Grady J., and Alexander J. Demonstration of Leishmania specific cell mediated and humoral immunity in asymptomatic dogs. Parasite Immunol. 14 (1992) 531-539
9. Cabral M., O'Grady J.E., Gomes S., Sousa J.C., Thompson H., and Alexander J. The immunology of canine leishmaniosis: strong evidence for a developing disease spectrum from asymptomatic dogs. Vet. Parasitol. 76 (1998) 173-180
10. Cardoso L., Neto F., Sousa J.C., Rodrigues M., and Cabral M. Use of a leishmanin skin test in the detection of canine Leishmania-specific cellular immunity. Vet. Parasitol. 79 (1998) 213-220
11. De Oliveira Mendes C., Paraguai de Souza E., Borja-Cabrera G.P., Maria Melo Batista L., Aparecida dos Santos M., Ellner Parra L., Menz I., Palatnik M., and Palatnik de Sousa C.B. IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis. Vaccine 21 (2003) 2589-2597
12. Deplazes P., Smith N.C., Arnold P., Lutz H., and Eckert J. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites. Parasite Immunol. 17 (1995) 451-458
13. Ferrer L. Clinical aspects of canine leishmaniasis. Proceedings of the International Canine Leishmaniasis Forum. Barcelona, Spain, 6-10 (1999)
14. Garg R., and Dube A. Animal models for vaccine studies for visceral leishmaniasis. Ind. J. Med. Res. 123 (2006) 439-454
15. Gramiccia M., and Gradoni L. The current status of zoonotic leishmaniases and approaches to disease control. Int. J. Parasitol. 35 (2005) 1169-1180
16. Gramiccia M., Gradoni L., and Orsini S. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment. Ann. Trop. Med. Parasitol. 86 (1992) 613-620
17. Handman E., and Hocking R.E. Stage-specific, strain-specific, and cross-reactive antigens of Leishmania species identified by monoclonal antibodies. Infect. Immun. 37 (1982) 28-33
18. Holzmuller P., Cavaleyra M., Moreaux J., Kovacic R., Vincendeau P., Papierok G., and Lemesre J.L. Lymphocytes of dogs immunised with purified excreted-secreted antigens of Leishmania infantum co-incubated with Leishmania infected macrophages produce IFN gamma resulting in nitric oxide-mediated amastigote apoptosis. Vet. Immunol. Immunopathol. 106 (2005) 247-257
19. Hommel M., Jaffe C.L., Travi B., and Milon G. Experimental models for leishmaniasis and for testing anti-leishmanial vaccines. Ann. Trop. Med. Parasitol. 89 Suppl. 1 (1995) 55-73
20. Lemesre J.L., Holzmuller P., Bras-Goncalves R., Bourdoiseau G., Hugnet C., Cavaleyra M., and Papierok G. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial. Vaccine 25 (2007) 4223-4234
21. Lemesre J.L., Holzmuller P., Cavaleyra M., Goncalves R.B., Hottin G., and Papierok G. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Vaccine 23 (2005) 2825-2840
22. Liew F.Y., and O'Donnell C.A. Immunology of leishmaniasis. Adv. Parasitol. 32 (1993) 161-259
23. Louis J., Himmelrich H., Parra-Lopez C., Tacchini-Cottier F., and Launois P. Regulation of protective immunity against Leishmania major in mice. Curr. Opin. Immunol. 10 (1998) 459-464
24. Martinez-Moreno A., Moreno T., Martinez-Moreno F.J., Acosta I., and Hernandez S. Humoral and cell-mediated immunity in natural and experimental canine leishmaniasis. Vet. Immunol. Immunopathol. 48 (1995) 209-220
25. Milon G., Del Giudice G., and Louis J.A. Immunobiology of experimental cutaneous leishmaniasis. Parasitol. Today 11 (1995) 244-247
26. Noguchi H. Comparative studies of herpetomonads and leishmaniasis. II. Differentiation of the organisms by serological reaction and fermentation tests. J. Exp. Med. 44 (1926) 327-337
27. Pinelli E., Killick-Kendrick R., Wagenaar J., Bernadina W., del Real G., and Ruitenberg J. Cellular and humoral immune responses in dogs experimentally and naturally infected with Leishmania infantum. Infect. Immun. 62 (1994) 229-235
28. Reiner S.L., and Locksley R.M. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13 (1995) 151-177
29. Ridley D.S. The pathogenesis of cutaneous leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 73 (1979) 150-160
30. Ridley D.S., Marsden P.D., Cuba C.C., and Barreto A.C. A histological classification of mucocutaneous leishmaniasis in Brazil and its clinical evaluation. Trans. R. Soc. Trop. Med. Hyg. 74 (1980) 508-514
31. Slappendel R.J. Canine leishmaniasis: a review based on 95 cases in The Netherlands. Vet. Q 10 (1988) 1-16
32. Tesh R.B. Control of zoonotic visceral leishmaniasis: is it time to change strategies?. Am. J. Trop. Med. Hyg. 52 (1995) 287-292